Byram H. Ozer, M.D., Ph.D.

Dr. Ozer completed a double major in biology and chemistry at New College of Florida before spending a year at the Max Planck Institute for Colloid Chemistry in Golm, Germany as a Fulbright Scholar. There, he studied self-assembly mechanisms of biomolecules in the laboratory of Charl FJ Faul. Dr. Ozer subsequently matriculated into the NIH-sponsored Medical Scientist Training Program at University of Wisconsin School of Medicine and Public Health, where he received both his M.D. and Ph.D.

He performed his dissertation work in the laboratory of Paul J. Bertics, exploring the role that the EGFR oncogene plays in the development of glioblastoma when mutated, and also using it as a model to study liquid crystal biosensor technology. He did his medical internship at Good Samaritan Hospital in Cincinnati, Ohio, before moving to the University of California, Los Angeles to complete both his neurology residency and his clinical and research fellowship in neuro-oncology. During this fellowship, he performed research in the laboratory of Albert M. Lai, characterizing epilepsy preponderance and exploring epigenetic and hypermutation changes in IDH-mutated gliomas. He subsequently started as an assistant professor at the Johns Hopkins Sidney Kimmel Cancer Center, with a primary appointment at their Washington, DC cancer center at Sibley Memorial Hospital. In 2022, Dr. Ozer joined the NCI-CONNECT (Comprehensive Oncology Network Evaluating Rare CNS Tumors) program to focus on rare CNS tumors. He is board certified in neurology from the American Board of Psychiatry and Neurology (ABPN) as well as in neuro-oncology from the United Council for Neurologic Subspecialties (UCNS).